Clinical Pearl

Metabolic bone disease is so common in end-stage liver disease and post-transplantation.  There are several reasons for this: prednisone use, cyclosporin use, hypogonadism, diabetes mellitus, hypovitaminosis D, hyperbilirubin, cholestatic liver diseases (PBC, PSC).

Advertisements
This entry was posted in Clinical Pearl. Bookmark the permalink.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s